Can Delta Variant Effectiveness Fill Brazil-Sized Hole In Bharat Biotech’s Prospects?

Ocugen Class Action Suit Could Get Tricky

 
• By Vibha Ravi
Covaxin vial
Bharat Biotech's Global Ambitions For Covaxin Have Landed It In Trouble • Source: Alamy

More from Business

More from Scrip